Overall rank by patents
#49,618
Across all tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 10 technology areas, active 2021–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B61L (GUIDING RAILWAY TRAFFIC; ENSURING THE SAFETY OF RAILWAY TRAFFIC).
The verdict
Protran holds 5 US patents across 10 technology areas, rank #49,618 of 50,000 tracked assignees.
Protran Technology, Llc has been granted 5 US utility patents between 2021 and 2023, placing Protran Technology, Llc at rank #49,618 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 23.4 claims per patent with primary concentration in B61L (GUIDING RAILWAY TRAFFIC; ENSURING THE SAFETY OF RAILWAY TRAFFIC). As a US Corporation, Protran Technology, Llc is one of the more focused assignees in the PatentsView dataset. By volume, Protran sits between Propst Family Limited Partnership (5 patents, rank #49,614) and Proxene Tools Co., Ltd. (5 patents, rank #49,622) - the closest US assignees by grant volume. The composite Innovation Score of 35.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2021 through 2023, with 5 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Protran Technology, Llc's 23.4 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Protran Technology, Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
PROPST FAMILY LIMITED PARTNERSHIP
5 patents
PROTERRGO INC.
5 patents
PROTEUM ENERGY, LLC
5 patents
PROTON MOTOR FUEL CELL GMBH
5 patents
PROVIDENCE PHOTONICS, LLC
5 patents
PROVISIONAL IMPLANT TECHNOLOGY, LLC
5 patents
PROVTAGAREN AB
5 patents
PROXENE TOOLS CO., LTD.
5 patents
PROTRAN TECHNOLOGY, LLC
5 patents
What this shows Protran holds 5 patents at rank #49,618, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #49,618 in granted patent volume.
Other assignees with the most granted patents in Protran's primary technology class.
Protran's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
36 Top 48% higher than 52% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 3 | 60.0% |
| 2023 | 2 | 40.0% |
Top 10 of 10 technology areas
Overall rank by patents
#49,618
Across all tracked assignees
35.9 out of 100
How to use this portfolio
Protran's 5 grants land it in the top 48% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.